Enhabit, Inc. · NYSE:EHAB
Enhabit — Goldman Sachs Global Healthcare Conference 2024
14 slides from Enhabit's conference presentation, Jun 11, 2024
Slide 1: Goldman Sachs Global Healthcare Conference June 11th 2024
Goldman Sachs Global Healthcare Conference June 11th 2024
Slide 2: Disclaimers - Forward looking statements
Enhabit Home Health & Hospice 1 Disclaimers Forward looking statements Statements contained in this presentation which are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All forward-looking information speaks only as of
Slide 3: 2024 Priorities
Enhabit Home Health & Hospice 2 2024 Priorities Home Health Hospice De Novos People Strategy • Stabilize Medicare as a % of total home health revenue • Leverage payor innovation strategy – Improve Medicare Advantage rates – Shift away from lower rate contracts • Grow through increased clinical staff
Slide 4: Home Health - Stabilize Traditional Medicare
Enhabit Home Health & Hospice 3 Home Health - Stabilize Traditional Medicare For basis of presentation, Enhabit figures are excluding private duty • Enhabit’s home health business historically had a relatively high mix of Medicare business • Anticipate mix shift to follow industry trends going forwa
Slide 5: Home Health - Payor Innovation
Enhabit Home Health & Hospice 4 Home Health - Payor Innovation Payor innovation strategy continues to foster Medicare Advantage growth. Driving steady increases in our non-Medicare revenue per visit 38% of non-Medicare visits are now in payor innovation contracts at improved rates. Visits from payor
Slide 6: Home Health – Growth
Enhabit Home Health & Hospice 5 Home Health – Growth • Improved clinical capacity • Increased favorable payor contracts • negotiated 64 new contracts since spin • Pipeline of 30 new agreements, with 28 historic agreements that are being re-negotiated • Utilizing technology to provide A Better Way to
Slide 7: Hospice
Enhabit Home Health & Hospice 6 Hospice Building the hospice segment for growth • New staffing model in place as of Q3 of 2023 • Staffing constraints eliminated • Recruitment and retention improvements • Focus turns to building sales headcount (currently have year over year increase) • Increases our
Slide 8: De Novo Strategy
Enhabit Home Health & Hospice 7 De Novo Strategy Launched in 2022 Cumulative de novo locations opened since 2022 Opened 15 De Novos since 2022 • Complementary of organic growth while being an efficient use of free cash flow • Continue to invest in attractive markets for overlap, scale and density •
Slide 9: People Strategy
Enhabit Home Health & Hospice 8 People Strategy Focus on Our Employees • Significant time and resources invested to ensure clinical and support staff receive the education, training, support and recognition necessary to provide the highest quality care in the most cost-effective manner • Consistentl
Slide 10: Long-Term Outlook
Enhabit Home Health & Hospice 9 Long-Term Outlook Source: MedPAC Report to Congress as of March 2021 & March 2023 1) Calculated based on 60 days per home health episode 2) US 75-79yrs Euromonitor National Population Statistics 3) AARP 2021 survey Our approach to home health and hospice services prio
Slide 11: Enhabit Home Health Long-Term Outlook
Enhabit Home Health & Hospice 10 Enhabit Home Health Long-Term Outlook Home health admissions have accelerated over the last two quarters Q2 2024 home health admissions have continued to grow versus prior year and expected to continue growing at mid- to high- single digits over the next three years
Slide 12: Enhabit Hospice Long-Term Outlook
Enhabit Home Health & Hospice 11 Enhabit Hospice Long-Term Outlook Sequential monthly growth in census in 2024 Expect hospice volumes to grow at mid- to high- single digits over the next three years after investing in the case management model and the build out of business development team
Slide 13: Free Cash Flow
Enhabit Home Health & Hospice 12 Free Cash Flow Enhabit has a proven track record of generating free cash flow, providing ample cash to: * - Q1 2024 free cash flow conversion rate positively influenced by the timing of payroll at the end of the quarter, which is expected to reverse in Q2 2024, provi
Slide 14: Important Additional Information and Where to Find It
Enhabit Home Health & Hospice 13 Important Additional Information and Where to Find It The Company has filed a definitive proxy statement on Schedule 14A and other documents with the SEC in connection with its solicitation of proxies from the Company’s stockholders for the Company’s 2024 annual meet
Enhabit — Goldman Sachs Global Healthcare Conference 2024 on 6ix